Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2008 | 09-2004 | 06-2004 | 03-2004 | 12-2003 | |
| Sales | 49,930 | 30,704 | 30,845 | 38,853 | 16,829 |
| Cost of Goods | 23,378 | 17,592 | 18,537 | 18,550 | 13,325 |
| Gross Profit | 26,552 | 13,112 | 12,308 | 20,303 | 3,504 |
| Operating Expenses | 25,780 | 12,809 | 11,950 | 11,113 | 8,798 |
| Operating Income | 1,150 | 895 | 895 | 9,740 | -4,969 |
| Interest Expense | 1,764 | 547 | 564 | 272 | 214 |
| Other Income | 1,642 | 387 | 271 | 56 | 81 |
| Pre-tax Income | 1,028 | 735 | 602 | 9,524 | -5,102 |
| Income Tax | 568 | N/A | 30 | 476 | N/A |
| Net Income Continuous | 460 | 735 | 572 | 9,048 | -5,102 |
| Net Income | $460 | $735 | $572 | $9,048 | $-5,102 |
| EPS Basic Total Ops | 0.01 | 0.01 | 0.01 | 0.16 | -0.09 |
| EPS Basic Continuous Ops | 0.01 | 0.01 | 0.01 | 0.16 | -0.10 |
| EPS Diluted Total Ops | 0.01 | 0.01 | 0.01 | 0.15 | -0.09 |
| EPS Diluted Continuous Ops | 0.01 | 0.01 | 0.01 | 0.15 | -0.10 |
| EBITDA(a) | $15,879 | $2,076 | $1,955 | $10,762 | $-3,968 |